(Q28510289)

25 January 2017

title

Immunomodulatory effects associated with a live vaccine against Leishmania major containing CpG oligodeoxynucleotides (English)

1 reference

25 January 2017

1 reference

GOA release 2020-03-11

1 reference

1 reference

1 reference

Yasmine Belkaid

3

0 references

author name string

Wenhui Wu

series ordinal

1

1 reference

25 January 2017

Luise Weigand

series ordinal

2

1 reference

25 January 2017

Susana Mendez

series ordinal

4

1 reference

25 January 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

European Journal of Immunology

25 January 2017

published in

1 reference

25 January 2017

volume

36

1 reference

25 January 2017

issue

12

1 reference

25 January 2017

page(s)

3238–3247

1 reference

A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.

25 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

Modulation of dendritic cell function by naive and regulatory CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

Vaccines against leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Synthetic oligodeoxynucleotides containing deoxycytidyl-deoxyguanosine dinucleotides (CpG ODNs) and modified analogs as novel anticancer therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

CpG Oligodeoxynucleotides Protect Normal and SIV-Infected Macaques from Leishmania Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

CpG oligodeoxynucleotides as vaccine adjuvants in primates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Cutaneous leishmaniasis: an increasing threat for travellers.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Cutaneous leishmaniasis in soldiers from Fort Campbell, Kentucky returning from Operation Iraqi Freedom highlights diagnostic and therapeutic options

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Induction and regulation of IFNs during viral infections

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636472

7 January 2021

Identifiers

DOI

10.1002/EJI.200636472

0 references

1 reference